15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Adagene Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $9.00 to $10.00, so the covering firms are broadly aligned. The average target of $9.50 sits 175% above the current $3.46. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 1 over recent months. On the fundamentals, the Street sees revenue growth near -100% this year and 0% next, consensus EPS building from about $-0.23 next quarter toward $-0.56 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Adagene Inc.
As of Sep, 1 of 1 firms rate ADAG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ADAG EPS & revenue forecast
EPS · NEXT QUARTER
$-0.23
Range $-0.24 – $-0.22 · 2 analysts
Next period, 2 analysts expect Adagene Inc to earn $-0.23 a share (range $-0.24 – $-0.22), versus — a year earlier. Full-year consensus is $-0.52, growing to $-0.56 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $1.6M, rising to $5.4M next year.
Top analysts covering Adagene Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ADAG.
#1
Arthur He
HC Wainwright & Co. · Rank #157
Buy
$7.00+102.3% to target
Overall win rate
50%
+ Follow
#2
Daina Graybosch
Leerink Partners · Rank #304
Buy
$7.00+102.3% to target
Overall win rate
40%
+ Follow
#3
PJ
Paul Jeng
Guggenheim
Buy
$10.00+189.0% to target
Coverage
—
+ Follow
#4
MS
Maxwell Skor
Morgan Stanley
Hold
No targeton ADAG
Coverage
—
+ Follow
#5
CL
Christopher Liu
LUCID CAPITAL MARKETS
Buy
$9.00+160.1% to target
Coverage
—
+ Follow
ADAG stock forecast FAQ
What is ADAG's average 12-month price target?+
The 2 analysts with a live target average $9.50 for Adagene Inc over the next 12 months, ranging from a $10.00 high to a $9.00 low.
Is ADAG stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ADAG?+
The Street-high target is $10.00 (Guggenheim), and the Street-low is $9.00 (LUCID CAPITAL MARKETS). The average of all 2 active targets is $9.50.
How many Wall Street analysts cover ADAG?+
2 analysts have an active rating on Adagene Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering ADAG?+
Among analysts who currently cover ADAG, Arthur He of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #157). Their current call is Buy with a $7.00 target.
What is Adagene Inc's projected EPS for next quarter?+
The consensus estimate is $-0.23 per share (range $-0.24 – $-0.22) across 2 analysts. Full-year EPS is projected at $-0.52, rising to $-0.56 the following year.
How much revenue is Adagene Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $1.6M, growing to $5.4M next year.
Have analysts been upgrading or downgrading ADAG lately?+
As of Sep, 1 of 1 firms rate ADAG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ADAG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
